StockData
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31

SINOVAC BIOTECH LTD

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026
$6.47+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
850.08%

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2025
Ended Dec 31, 2025
Jan 5, 2026During market hours–––

Press releases

Announcements Sinovac Biotech filed with the SEC